Abstract
The clinical usefulness of azithromycin (AZM), a newly developed macrolide antibacterial agent, on various infections in the internal field was examined in this study. The drug was administered to 3 patients, 1 with mycoplasma pneumonia and 2 with acute tonsillitis, at a dose of 500mg once a day for 3 days. The result was evaluated as excellent, good and fair in 1 case each. No pathogenic bacterium was isolated in any case, so the bacteriological effect was unclear. Although no adverse reactions were observed, abnormally changed laboratory values were detected, including slightly elevated GOT, GPT and LDH in 1 case.
